Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2000
09/26/2000US6124255 Preparation comprising thiol-group-containing proteins
09/26/2000US6124133 Antisense inhibition of fra-1 expression
09/26/2000US6124131 Protein associated with incresed oxygen demand; for treatment and prevention of tissues damage caused by lack of oxygen
09/26/2000US6124123 UBCH7-like ubiquitin-conjugating enzyme
09/26/2000US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides
09/26/2000US6124118 Receptor recognition factors, protein sequences and methods of use thereof
09/26/2000US6124116 Nucleotide sequence coding human guanidine triphosphatase; for the diagnosis, prevention, or treatment of vision defects, acquired immune deficiency syndrome, and cancer; anticarcinogenic agents
09/26/2000US6124114 Nucleotide sequences coding globin like polypeptides; for use as blood replacements
09/26/2000US6124101 Diagnosis of thrombosis in a mammals; incubating a sample of fluid with an antibody that preferentially binds a cleaved activation peptide, counting antibody bound cleaved activation peptides, compare to control
09/26/2000US6124095 Human nucleotide pyrophosphohydrolase-2
09/26/2000US6124091 Cell growth-controlling oligonucleotides
09/26/2000US6123957 Combining at least one tissue regenerative agent with at least one cellular recognition agent(cra) to form a therapeutic treatment composition and applying it to a periodontal treatment site; cra increases tissue regeneration
09/26/2000US6123942 Bacterial hemoglobin receptor gene
09/26/2000US6123941 Method for restoration of normal phenotype in cancer cells
09/26/2000US6123938 Human urinary hyaluronidase
09/26/2000US6123937 Prevention or therapeutic treatment of a disease or bodily condition of a mammal, which is caused by a hormonal or metabolic disorder such as cystic ovarian diseases in cow by administering to a cow a lysoenzyme dimer
09/26/2000US6123936 Methods and compositions for the dry powder formulation of interferons
09/26/2000US6123916 For treating disorders with an aetiology comprising or associated with excess of gh-secretion
09/26/2000CA2200069C Anti-fungal peptides
09/26/2000CA2190011C Method for reduction of headache pain
09/26/2000CA2137832C Inhibitors of angiotensin i chymase(s) including human heart chymase
09/26/2000CA2018461C Novel polypeptides and their use
09/21/2000WO2000055633A2 Methods of screening for colorectal cancer modulators
09/21/2000WO2000055375A1 Secreted proteins and polynucleotides encoding them
09/21/2000WO2000055374A1 Methods and compositions for inhibition of rna splicing
09/21/2000WO2000055371A1 27 human secreted proteins
09/21/2000WO2000055352A2 50 human secreted proteins
09/21/2000WO2000055351A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000WO2000055350A1 Human cancer associated gene sequences and polypeptides
09/21/2000WO2000055345A2 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes
09/21/2000WO2000055344A1 Adenoviral vector expressing a sv40 t antigen antisense rna
09/21/2000WO2000055341A1 Anti-viral vectors
09/21/2000WO2000055332A2 Human regulators of intracellular phosphorylation
09/21/2000WO2000055330A1 Polysaturated fatty acid (pufa) elongase from caenorhabditis elegans
09/21/2000WO2000055326A1 Chlamydia antigens and corresponding dna fragments and uses thereof
09/21/2000WO2000055324A1 Murine interferon-alpha named also zcyto13
09/21/2000WO2000055323A1 Differential expression of organellar gene products
09/21/2000WO2000055321A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000WO2000055320A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000WO2000055319A1 Methods and compositions for inhibiting neoplastic cell growth
09/21/2000WO2000055318A2 Abc1 polypeptide and methods and reagents for modulating cholesterol levels
09/21/2000WO2000055317A1 Bsmap, a surface protein expressed specifically in the brain
09/21/2000WO2000055316A1 Rna polymerase i transcription factor tif-ia
09/21/2000WO2000055314A2 Inhibitors of endothelin-1 synthesis
09/21/2000WO2000055210A1 Method for the reductive amination of polysaccharides
09/21/2000WO2000055207A1 A novel chimeric protein for prevention and treatment of hiv infection
09/21/2000WO2000055206A1 Endothelial cell stimulation by a complex of fibronectin and vascular endothelial growth factor
09/21/2000WO2000055205A1 ISOFORMS OF MOUSE SEROTONIN 5-HT2c RECEPTOR
09/21/2000WO2000055204A1 Interleukin 17 receptor-like protein
09/21/2000WO2000055201A1 49 human secreted proteins
09/21/2000WO2000055200A1 50 human secreted proteins
09/21/2000WO2000055199A1 47 human secreted proteins
09/21/2000WO2000055198A1 50 human secreted proteins
09/21/2000WO2000055197A1 Novel proteins and uses thereof
09/21/2000WO2000055196A1 Protamine fragment compositions and methods of use
09/21/2000WO2000055195A1 Compositions for promoting nerve regeneration
09/21/2000WO2000055194A2 Tuberculosis antigens and methods of use therefor
09/21/2000WO2000055193A2 Human dan/cerberus related protein 6 (dcr6)
09/21/2000WO2000055192A2 Hemocyanin and nucleic acid sequence coding for the same
09/21/2000WO2000055190A1 Novel lhrh antagonists with improved solubility characteristics
09/21/2000WO2000055189A1 Dalda analogs and their use
09/21/2000WO2000055188A1 Substituted proline derivatives and medicinal compositions containing the same
09/21/2000WO2000055187A1 Therapeutic and diagnostic applications of p400: a newly discovered beta-amyloid binding protein present in human biological fluids
09/21/2000WO2000055186A1 Antibiotic wap-2607b, process for producing the same and antibacterial agents
09/21/2000WO2000055183A1 Method for refolding molecules of polypeptides containing ig domains
09/21/2000WO2000055181A1 Methods of modulating cell attachment and migration
09/21/2000WO2000055180A2 Human lung cancer associated gene sequences and polypeptides
09/21/2000WO2000055177A2 49 human secreted proteins
09/21/2000WO2000055176A2 49 human secreted proteins
09/21/2000WO2000055175A1 50 human secreted proteins
09/21/2000WO2000055174A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000WO2000055173A1 Human breast and ovarian cancer associated gene sequences and polypeptides
09/21/2000WO2000055171A1 50 human secreted proteins
09/21/2000WO2000055169A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS
09/21/2000WO2000055156A1 Substituted aromatic amidine derivative and medicinal composition comprising the same
09/21/2000WO2000055154A1 Modified amino-acid amides as cgrp antagonists
09/21/2000WO2000055133A1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors
09/21/2000WO2000055127A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
09/21/2000WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000WO2000054814A1 Screening methods for compounds useful in the regulation of cell proliferation
09/21/2000WO2000054813A2 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
09/21/2000WO2000054806A1 Insulin-like growth factor binding protein-4 protease
09/21/2000WO2000054805A1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS
09/21/2000WO2000054804A1 Use of tgf-beta inhibitors for treating cerebral disorders
09/21/2000WO2000054801A1 Compositions and methods of use of ldl-like receptor ligands for the treatment of cancer and angiogenic-based disease
09/21/2000WO2000054800A1 Preventives/remedies for digestive diseases
09/21/2000WO2000054799A2 Medicament for treating diabetes
09/21/2000WO2000054798A1 Antiviral agent in the form of nose drops
09/21/2000WO2000054797A2 Pharmaceutical compositions comprising tgf-beta
09/21/2000WO2000054796A1 Novel antiangiogenic peptides
09/21/2000WO2000054795A1 Combined therapy with a chemotherapeutic agent and an oncolytic virus for killing tumor cells in a subject
09/21/2000WO2000054790A1 Immunostimulant bacterial membrane fractions in cancer treatment
09/21/2000WO2000054789A1 Bacterial membrane fractions with adjuvant effect
09/21/2000WO2000054787A1 Enhanced gamma-carboxylation of recombinant vitamin k-dependent clotting factors
09/21/2000WO2000054786A1 Methods and compositions for tolerizing hosts for long term survival of tissue transplants
09/21/2000WO2000054785A2 Stabilized bicyclo[3.3.1]nonenes and methods of use
09/21/2000WO2000054783A1 Treatment of asthma
09/21/2000WO2000054779A1 OCULAR THERAPY IN KERATOCONJUCTIVITIS SICCA USING TOPICALLY APPLIED ANDROGENS OR TGF-$g(b)
09/21/2000WO2000054770A1 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
09/21/2000WO2000054760A2 Bicyclo (3.3.1) nonenes useful for the treatment of diabetes and hypertriglyceridemia
1 ... 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 ... 3163